Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shuangjin weichang jiaonang
- Development stage
- Unknown
- Lead developer
- Shaanxi Momentum Pharmaceutical
- Administration
- Oral
01
Overview
Shuangjin Weichang Jiaonang is an approved traditional Chinese medicine (TCM) capsule developed and manufactured by Shaanxi Momentum Pharmaceutical. It is formulated from a mixture of 13 traditional Chinese herbs, including Sepiae Endoconcha (Haipiaoxiao), Bletillae Rhizoma (Baiji), Toosendan Fructus (Chuanlianzi), Corydalis Rhizoma (Yanhusuo), Coptidis Rhizoma (Huanglian), Evodiae Fructus (Wuzhuyu), Cyperi Rhizoma (Xiangfu), Nardostachyos Radix et Rhizoma (Gansong), Curcumae Radix (Yujin), Curcumae Rhizoma (Ezhu), Citri Reticulatae Pericarpium (Chenpi), Pinelliae Rhizoma (Banxia), and Gigeriae Galli Endoconcha (Jineijin). The formulation is indicated for the treatment of gastric and duodenal ulcers, specifically those presenting with liver-stomach qi stagnation and blood stasis. It functions to soothe the liver, harmonize the stomach, suppress acid secretion, and alleviate pain.
- Brand names
- MeideMomeide
- Other names
- Shuangjin Weichang Jiaonang双金胃肠胶囊
02
Targets
BCL-2 (BCL-2 family)CASP3 (Caspase-3)CASP9 (Caspase-9)CPT2 (Carnitine O-palmitoyltransferase 2)EGFR (Epidermal growth factor receptor)IL1B (Interleukin-1 beta)IL-2 (Interleukin 2)IL-6 (Interleukin 6)MMP9 (Matrix metalloproteinase-9)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NOS3 (eNOS)STAT3 (Signal Transducer and Activator of Transcription 3)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on shuangjin weichang jiaonang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shuangjin weichang jiaonang.